Companies / Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc.

TERNCIK 1831363FOSTER CITY, CA

Financials · FY2022

Revenue$0
Net income$-96.21M
Total debt$1.03M
Cash$524.75M
Diluted EPS$-1.03
Shares outstanding115.5M

Ownership

115.5M shares outstanding · as of Apr 17, 2026
0.43%Insiders
Ownership
Insiders0.43%497,379
10%+ / strategic2.73%3,150,000
Institutions112.01%129,390,111
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 9

View all →
Insider% of sharesShares
Burroughs Amy L.CEOChief Executive Officer · Director
0.25%288,976
Kuriakose EmilChief Medical Officer
0.09%106,615
Gengos AndrewChief Financial Officer
0.09%101,788
Azelby RobertDirector
——
Fellows David aDirector
——
Kindler Jeffrey BDirector
——
Quigley Jill M.Director
——
Tripuraneni RadhikaDirector
——
Turner Heather DDirector
——

Institutional holders 281

View all →
HolderValue% of shares
BlackRock, Inc.$331.05M7.09%
Morgan Stanley$321.00M6.88%
Vanguard Group Inc$223.17M4.78%
Vivo Capital, LLC$216.02M4.63%
Vestal Point Capital, LP$181.80M3.90%
Avoro Capital Advisors LLC$175.74M3.77%
Millennium Management LLC$158.77M2.61%
Hbk Investments L P$155.52M2.55%
Balyasny Asset Management L.P.$146.53M2.41%
Citadel Advisors LLC$127.93M2.74%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 5, 2026Burroughs Amy L.
CEO
SellCommon Stock$2.72M-71K
-33.92%
138,976
0.12% of shares
medium
Jan 15, 2026Burroughs Amy L.
CEO
SellCommon Stock$2.27M-61K
-17.12%
296,497
0.26% of shares
medium
Mar 16, 2026Burroughs Amy L.
CEO
SellCommon Stock$550.1K-12K
-3.89%
291,746
0.25% of shares
medium
Feb 17, 2026Burroughs Amy L.
CEO
SellCommon Stock$320.0K-8K
-2.71%
293,059
0.25% of shares
medium
Jan 15, 2026Burroughs Amy L.
CEO
SellCommon Stock$282.2K-8K
-2.54%
288,976
0.25% of shares
medium
Feb 17, 2026Burroughs Amy L.
CEO
SellCommon Stock$162.5K-4K
-1.39%
288,976
0.25% of shares
medium
Mar 16, 2026Burroughs Amy L.
CEO
SellCommon Stock$131.0K-3K
-0.95%
288,976
0.25% of shares
medium
Jan 15, 2026Burroughs Amy L.
CEO
ExerciseCommon Stock$125.7K+27K
+8.57%
343,142
0.30% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Adage Capital Management, L.P.Passive13G———
Soleus Capital Master Fund, L.P.Passive13G/A———
Deep Track Capital, LPPassive13G/A—3,150,000—
Vivo Opportunity Fund Holdings, L.P.Passive13G/A———
Commodore Capital LPPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
TERN——880881107—